Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aclaris Therapeutics, Inc. | 56,025 | reported | 03 Feb 2026 | tx 10+1,296,125−45,425 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 96,100 | 0.00 USD | deriv |
| 02 Feb 2026 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 336,300 | 0.00 USD | deriv |
| 03 Feb 2026 | EXERCISE | Aclaris Therapeutics, Inc. | 18,675 | — | |
| 03 Feb 2026 | EXERCISE | Aclaris Therapeutics, Inc. | 18,675 | 0.00 USD | deriv |
| 02 Dec 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 26,750 | — | |
| 02 Dec 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 26,750 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 261,600 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 74,700 | 0.00 USD | deriv |
| 02 Dec 2024 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 107,000 | 0.00 USD | deriv |
| 02 Dec 2024 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 375,000 | 0.00 USD | deriv |